Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

ML-3000 progresses through the pipeline

Dec. 18, 1996

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

MMP/TNF inhibitors reported by Pfizer

Dec. 12, 1996

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

FDA tentatively approves generic NSAID

Dec. 6, 1996

SKB, IDEC initiate phase III testing of antirheumatic antibody

Dec. 6, 1996

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

Dec. 6, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...